心筋不全症候群:国際臨床ガイドラインの進化を調和させるための新しい命名法
William E Boden1, Raffaele De Caterina1, Juan Carlos Kaski2
1VA Boston Healthcare System, Boston University School of Medicine, Boston, MA (W.E.B.).
Circulation
|August 30, 2024
まとめ
心筋不全症候群の新用語は,分類を統一し,患者のケアを改善するために提案されています. これは阻害的および非阻害的原因の両方をカバーし,アンギナと心臓発作の診断と治療戦略を強化することを目的としています.
科学分野:
- 心臓病科
- 医学用語
- 発血性心臓病
背景:
- 現在,心筋梗塞症の分類は一貫性がないため",安定した冠動脈疾患" (CAD),"安定した心筋梗塞疾患",および"慢性冠動脈症候群" (CCS) のような用語を使用しています.
- 矛盾するガイドライン (ヨーロッパ対アメリカ) と制限的な用語は,しばしば非阻害的なメカニズムを無視して,CADの狭い視点を永続させます.
- 既存の分類は,胸痛と心筋不全の様々な原因を包括的に扱わず,概念の明確さと統一された管理を妨げています.
研究 の 目的:
- 心筋不全症候群のための新しい,包括的な二元分類を提案する.
- マイクロ血管機能障害や血管縮性障害を含む,阻害性および非阻害性両方の原因を含む用語を開発する.
- 診断と治療の改善のための国際ガイドラインの間の不協調な分類を調和させる.
主な方法:
- 急性心筋梗塞 (MI) と慢性的な安定した心筋不全症の分類システムのレビューと分析
- "急性心筋不全症候群"と"非急性心筋不全症候群"という新しい二元分類の開発.
- 既存のカテゴリー (ACS,STEMI,NSTEMIなど) と新しい概念 (非阻害性冠動脈を持つMIなど) を提案された枠組みに統合する.
主要な成果:
- "急性心筋不全症候群"と"非急性心筋不全症候群"の二元分類を提案した.
- 新しい分類は,マイクロ血管機能障害,血管縮障害,冠動脈以外の原因を含む,阻害性表心および非阻害性病原性メカニズムを組み込む.
- 既定のMIカテゴリーを維持しながら,不血症と非阻塞性冠動脈性MIの新しい用語に対応します.
結論:
- 提案された分類は,心筋不全の理解のためのより包括的な枠組みを提供します.
- この統一された用語は,アンギナ,缺血,心臓発作の複数の病理学的原因に対処することによって,診断と治療の戦略を洗練することを目的としています.
- この包括的な分類を採用すると,より標的型な患者治療と,心不全の治療結果の改善につながります.
関連する概念動画
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Antianginal Drugs: Nitrates and β-Blockers
547
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
547
Imaging Studies for Cardiovascular System I:Echocardiography
303
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
303
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


